C12Y 102/03004
Oxalate oxidase
Official title: Oxalate oxidase (1.2.3.4)
C12Y102/03004 (Oxalate oxidase) appears on 21 US grants and 19 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 19
- Assignees
- 20
- Inventors
- 48
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 5 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 1 | 1 |
| 2019 | 2 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and compositions for treating hyperoxaluria23 Sep 2025US 12,421,518 B2Tenza, Inc.
- Hematin modified bilirubin oxidase cathode30 May 2023US 11,664,504 B2CFD Research Corporation
- High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate14 Mar 2023US 11,603,524 B2Oxidien Pharmaceuticals, LLC
- Alcohol based biofuel cell5 Oct 2021US 11,139,500 B2CFD Research Corporation
- Hematin modified bilirubin oxidase cathode21 Sep 2021US 11,127,966 B2CFD Research Corporation
- American chestnut leaf compositions comprising oxalate oxidase and methods for treatment of oxalate-related disorders12 Oct 2023US 2023/0321202 A1The Research Foundation for The State University of New York (RFSUNY)
- High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate22 Sep 2022US 2022/0298497 A1
- Methods and compositions for treating hyperoxaluria20 Jan 2022US 2022/0017909 A1Novome Biotechnologies, Inc.
- Hematin modified bilirubin oxidase cathode9 Dec 2021US 2021/0384520 A1CFD Research Corporation
- Hematin modified bilirubin oxidase cathode23 Jan 2020US 2020/0028181 A1CFD Research Corporation
Most cited
By later US patents
- Method for reducing oxalate53US 6,281,252 B1GelTex Pharmaceutical, Inc. · 2001
- Method for reducing oxalate40US 5,985,938 AGelTex Pharmaceuticals, Inc. · 1999
- Method for reducing oxalate31US 6,177,478 B1GelTex Pharmaceuticals, Inc. · 2001
- Oxalate oxidase composition for assay of oxalate19US 4,455,371 AThe Ohio State University Research Foundation · 1984
- Compositions and methods for treating or preventing oxalate-related disease19US 8,486,389 B2Oxthera, Inc. · 2013